Adamane Shraddha A, Mittal Neha, Teni Tanuja, Pawar Sagar, Waghole Rohit, Bal Munita
Department of Pathology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, 400012, India.
Teni Lab, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Kharghar, Navi Mumbai, 410 210, India.
Head Neck Pathol. 2019 Sep;13(3):331-338. doi: 10.1007/s12105-018-0969-4. Epub 2018 Sep 26.
Human papillomavirus (HPV)-related multiphenotypic sinonasal carcinoma (HMSC) is a recently described distinctive clinicopathologic entity defined by association to high risk HPV, localization to sinonasal tract and close histologic resemblance to salivary gland tumors. Lack of awareness of its pathologic features and biology among pathologists and oncologists make this entity susceptible to misdiagnosis and erroneous management. Herein, we illustrate a case of HMSC of the nasal cavity associated with heretofore unreported subtype HPV-52 and discuss the challenges associated with diagnosis and management of this rare tumor. A 48-year-old woman with intermittent epistaxis for 6 months presented with a nasal mass and underwent middle turbinectomy. Histology showed a tumor with features typical of adenoid cystic carcinoma (ACC) in the form of basaloid cells and cribriform architecture. However, careful inspection revealed findings uncommon in ACC; such as surface pagetoid tumor spread, areas of solid sheets of myoepithelial cells accompanied by increased mitotic figures which prompted immunohistochemistry. Multidirectional differentiation into ductal (CK7, AE1/AE3) and myoepithelial (p63, p40, S100, calponin) lineage together with strong and diffuse immunopositivity for p16 distinguished this tumor from ACC. HPV genotyping was positive for high risk HPV subtype HPV52, which confirmed the diagnosis of HMSC. HPV-related multiphenotypic sinonasal carcinoma is an under-recognized unique clinicopathologic entity that needs awareness to avoid mistaking it for commoner salivary gland tumors. Making accurate diagnosis of this newly-described tumor is imperative in order to understand its biology and to develop optimal therapeutic strategies.
人乳头瘤病毒(HPV)相关的多表型鼻窦癌(HMSC)是一种最近描述的独特临床病理实体,其定义为与高危HPV相关、定位于鼻窦道且在组织学上与涎腺肿瘤极为相似。病理学家和肿瘤学家对其病理特征和生物学特性认识不足,使得该实体易于被误诊和错误处理。在此,我们阐述一例鼻腔HMSC病例,其与迄今未报告的HPV - 52亚型相关,并讨论该罕见肿瘤诊断和处理中存在的挑战。一名48岁女性,有6个月间歇性鼻出血,出现鼻腔肿物并接受了中鼻甲切除术。组织学显示肿瘤具有腺样囊性癌(ACC)的典型特征,呈基底样细胞和筛状结构。然而,仔细检查发现了ACC中不常见的表现;如表面派杰样肿瘤扩散、实性片状肌上皮细胞区域伴有有丝分裂象增加,这促使进行免疫组化检查。向导管(CK7、AE1/AE3)和肌上皮(p63、p40、S-100、钙调蛋白)谱系的多向分化以及p16的强而弥漫性免疫阳性将该肿瘤与ACC区分开来。HPV基因分型显示高危HPV亚型HPV52呈阳性,这证实了HMSC的诊断。HPV相关的多表型鼻窦癌是一种未被充分认识的独特临床病理实体,需要提高认识以避免将其误诊为更常见的涎腺肿瘤。准确诊断这种新描述的肿瘤对于了解其生物学特性并制定最佳治疗策略至关重要。